loading

Caribou Biosciences Inc Azioni (CRBU) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
79.30%
3.941
2.198 2.667 2.353 2.077
Operating Expenses
2.52%
32.39
31.60 50.24 45.27 40.95
Benefits Costs and Expenses
30.98
- - 42.34 37.58
Costs And Expenses
1.96%
30.98
31.60 50.24 42.34 37.58
Operating Income/Loss
3.22%
-28.45
-29.40 -47.58 -42.91 -38.88
Nonoperating Income/Loss
23.60%
1.415
1.852 -6.52 2.922 3.376
Income/Loss From Continuing Operations Before Tax
1,330%
-27.04
2.198 -54.10 -39.99 -35.50
Income Tax Expense/Benefit
-0.55
- - - -0.009
Income/Loss From Continuing Operations After Tax
3.85%
-26.49
-27.55 -54.10 -39.99 -35.49
Net Income/Loss
3.85%
-26.49
-27.55 -54.10 -39.99 -35.49
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.59%
0.3866
93.29 93.03 92.68 0.2831
Diluted Average Shares
99.59%
0.3866
93.29 93.03 92.68 0.2831
Basic Earnings Per Share
6.67%
-0.28
-0.30 -0.58 -0.43 -0.39
Diluted Earnings Per Share
6.67%
-0.28
-0.30 -0.58 -0.43 -0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):